Healthy Dialogue

Latest Episodes:

Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic Oct 15, 2020

Show notes

Interview with Christopher W. Seymour, MD, MSc, author of Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic

The Surgeon General's Call to Action to Control Hypertension Oct 09, 2020

Show notes

The US Surgeon General's office has released a report emphasizing the importance of making hypertension control a national public health priority. Vice Admiral Jerome Adams, MD, MPH, the 20th US Surgeon General, discusses the report's background and recommendations. Recorded October 7, 2020.

Related Article(s):

A National Commitment to Improve the Care of Patients With Hypertension in the US

Coronavirus Vaccine Update From the FDA Oct 07, 2020

Show notes

Peter Marks, MD, PhD, directs the US FDA's Center for Biologics Evaluation and Research (CBER) and will "call the balls and strikes" on any COVID-19 vaccine, according to FDA Commissioner Stephen Hahn. He joins JAMA Editor Howard Bauchner, MD, for an update on vaccine progress to date and prospects for pre-election political interference in the FDA approval process. Recorded October 5, 2020.

Related Article(s):

Unwavering Regulatory Safeguards for COVID-19 Vaccines

Who Gets Coronavirus Vaccine First? Oct 07, 2020

Show notes

On October 2 the US National Academies of Science, Engineering, and Medicine issued its consensus Framework for Equitable Allocation of a COVID-19 Vaccine. William H. Foege, MD, MPH, emeritus distinguished professor of International Health at the Rollins School of Public Health at Emory University, cochaired the committee that authored the report and discusses its recommendations. Recorded October 2, 2020.

Fairly Prioritizing Groups for Access to COVID-19 Vaccines

De-Adopting Low-Value Care—Evidence, Eminence, and Economics Oct 02, 2020

Show notes

Interview with William H. Shrank, MD, author of De-adopting Low-Value Care: Evidence, Eminence, and Economics

Related Article(s):

De-adopting Low-Value Care

Coronavirus Q&A With Anthony Fauci, MD – September 25, 2020 Sep 29, 2020

Show notes

Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the latest developments in the COVID-19 pandemic. Recorded September 25, 2020.

Related Article(s):

Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine

Coronavirus Update With Michael T. Osterholm, PhD, MPH Sep 25, 2020

Show notes

Michael T. Osterholm, PhD, MPH, returns to JAMA's Coronavirus Q&A series to discuss the latest developments in the COVID-19 pandemic. He is director of the Center for Infectious Disease Research and Policy (CIDRAP) at University of Minnesota and a veteran of pandemic planning. Recorded September 23, 2020.

Related Article(s):

Fairly Prioritizing Groups for Access to COVID-19 Vaccines

COVID-19 Vaccine Approval and the FDA Sep 23, 2020

Show notes

Hydroxychloroquine and convalescent plasma approvals by the FDA under Emergency Use Authorization (EUA) protocols have raised concerns the agency is under withering political pressure to fast-track a COVID-19 vaccine before it is proven safe and effective. Joshua Sharfstein, MD, Johns Hopkins Bloomberg School of Public Health, and JAMA Associate Editor Preeti Malani, MD, University of Michigan, discuss implications for public health and policy responses to ensure vaccine safety. Recorded September 18, 2020.

Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine

Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency Sep 15, 2020

Show notes

Interview with Aaron S. Kesselheim, MD, author of Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency

Related Article(s):

Regulatory Decision-making on COVID-19 Vaccines During a Public Health Emergency

Hypertension, Obesity, and COVID-19 Sep 14, 2020

Show notes

New data show unfavorable US trends in hypertension and obesity, with communities of color doing worse. National Institute of Diabetes and Digestive and Kidney Diseases Director Griffin P. Rodgers, MD, and National Heart, Lung, and Blood Institute Director Gary H. Gibbons, MD, discuss the implications for COVID-19 outcomes and public health. Recorded September 10, 2020.

Related Article(s):

Trends in Blood Pressure Control Among US Adults With Hypertension, 1999-2000 to 2017-2018